Clinical Trial Update: Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating memantine for cognitive impairment in patients with systemic lupus erythematosus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED